In a collaboration that promises to accelerate cutting-edge research and foster tomorrow’s medical discoveries, Stony Brook Medicine and Mount Sinai Health System have entered into an affiliation agreement aimed at heightening research collaboration and enhancing academic programs and clinical care initiatives.

Stony Brook University President Samuel L. Stanley Jr., MD, (center) shakes hands with Kenneth Kaushansky, MD, Senior VP, Health Sciences and Dean, Stony Brook University School of Medicine (left), and Dennis S. Charney, MD, the Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, and President, Academic Affairs, Mount Sinai Health System (right) after signing the affiliation agreement.
“This is a momentous day for academic medicine, health care, our respective students, faculty and staff, and for all those who are cared for by our teams of highly trained, dedicated clinicians,” said Stony Brook University President Samuel L. Stanley Jr., MD. “Each institution has so much to offer, so this is an opportunity that will prove to be beneficial for all — now and in the future — as we explore and grow this incredible collaboration.”

Leaders from Stony Brook University and the Mount Sinai Health System, along with elected officials, assemble at the affiliation agreement signing event at Stony Brook Medicine. From left: Assemblyman Steven Englebright; Scott Friedman, MD, Dean of Therapeutic Discovery at Icahn School of Medicine at Mount Sinai; Dennis S. Charney, MD, the Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai and President of Academic Affairs, Mount Sinai Health System; Samuel L. Stanley Jr., MD, President of Stony Brook University; Kenneth Kaushansky, MD, Senior VP, Health Sciences and Dean, Stony Brook University School of Medicine; Senator Kenneth LaValle; Senator Kemp Hannon; and Lina Obeid, MD, Dean for Research and Vice Dean for Scientific Affairs, Stony Brook University School of Medicine.
“The opportunities for amazing science to spring from our collaborative efforts are truly boundless,” said Kenneth Kaushansky, MD, Senior Vice President for Health Sciences, and Dean of the Stony Brook University School of Medicine. “When you bring the intellectual and biomedical horsepower of the Icahn School of Medicine faculty together with the outstanding neuroscientists, cancer biologists, imaging innovators, cardiovascular experts, and leading biomedical informaticists of the Stony Brook School of Medicine, as well as the world-class departments of computer sciences, biomedical engineering, chemistry, and applied mathematics at Stony Brook University, the possibilities are staggering.”